Article

The State of Ovarian Cancer: Surgical Practices and Management

Author(s):

An OncLive® Weekly Webinar Series highlighting best practices, treatment updates, and multidisciplinary approaches to ovarian cancer care through the COVID-19 pandemic. Join us Wednesday, May 13, 2020 at 8 PM EST.

Date/Time: Wednesday, May 13, 2020 at 8 PM EST

An OncLive® Weekly Webinar Series highlighting best practices, treatment updates, and multidisciplinary approaches to ovarian cancer care through the COVID-19 pandemic.

In the second webinar of our series, we will take an in-depth look at gynecologic surgery and how approaches have changed during the COVID-19 pandemic.

Click here to register today!

The following objectives will be reviewed:

  • Impact of the COVID-19 pandemic on the diagnosis and screening of patients with ovarian cancer
  • Navigating through challenging treatment decisions for patients with ovarian cancer during the pandemic
  • How clinical trials have been affected and the expanding role of telemedicine

Clinical Director University of Cincinnati Cancer Institute; Professor of Obstetrics and Gynecology, UC College of Medicine

Professor, Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital Phoenix, USA; Medical Director, US Oncology Research Network - Gynecologic Program; Co-director GOG-Partners; Member Board of Director GOG-Foundation

Professor of Gynecologic Oncology; Associate Director of Gynecologic Oncology; Levine Cancer Institute, Atrium Health

Sponsored By:

Related Videos
Laura J. Chambers, DO
Domenica Lorusso, MD, PhD
Domenica Lorusso, MD, PhD
Domenica Lorusso, MD, PhD
Laura J. Chambers, DO
Angeles A. Secord, MD, MHSc
Angeles A. Secord, MD, MHSc, professor, obstetrics and gynecology, Duke Cancer Institute, discusses findings from the phase 2 PICCOLO trial (NCT05041257) investigating mirvetuximab soravtansine-gynx (Elahere) in patients with recurrent, platinum-sensitive ovarian cancer with high folate receptor alpha (FRα) expression.
Kimberly Cannavale, MPH
Kimberly Cannavale, MPH
Amma Asare, MD, PhD